Placitas, NM, United States of America

Erin Damita Milligan

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Erin Damita Milligan: Innovator in Pain Management and Biosensing Technologies

Introduction

Erin Damita Milligan is a prominent inventor based in Placitas, NM (US). She has made significant contributions to the fields of pain management and biosensing technologies. With a total of 4 patents, her work focuses on innovative methods to address chronic neuropathic pain and the development of advanced biosensors.

Latest Patents

One of her latest patents is titled "Control of chronic neuropathic pain and allodynia." This invention provides a method for treating subjects suffering from chronic neuropathic pain and/or allodynia by administering a therapeutically-effective amount of at least one LFA1 antagonist. In a preferred embodiment, the method includes administering intrathecally a therapeutically-effective amount of microparticles comprising PLGA-encapsulated pDNA-IL-10, optionally in combination with a therapeutically-effective amount of intrathecally-administered CpG oligodeoxynucleotide (CpG ODN) and/or at least one LFA1 antagonist. Another notable patent is the "Compact biosensor of matrix metalloproteinase with cadmium free quantum dots." This invention features a quantum dot (QD) modified optical fiber-based biosensor that characterizes matrix metalloproteinase (MMP) enzyme activity at pain signaling sites in the central nervous system (CNS) in vivo.

Career Highlights

Erin Milligan has established herself as a leading figure in her field through her innovative research and development efforts. Her work has not only advanced scientific understanding but also provided practical solutions for managing chronic pain.

Collaborations

Erin has collaborated with notable colleagues, including John Bryan Plumley and Marek A Osinski, to further enhance her research and development initiatives.

Conclusion

Erin Damita Milligan's contributions to pain management and biosensing technologies exemplify her dedication to innovation. Her patents reflect her commitment to improving the quality of life for individuals suffering from chronic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…